Literature DB >> 7929442

Stimulation of poliovirus proteinase 3Cpro-related proteolysis by the genome-linked protein VPg and its precursor 3AB.

A Molla1, K S Harris, A V Paul, S H Shin, J Mugavero, E Wimmer.   

Abstract

Purified recombinant poliovirus polypeptide 3AB interacts with 3CDpro and 3Dpol as shown by coimmunoprecipitation with anti-3Dpol antibodies. A consequence of this interaction is an accelerated autoprocessing of 3CDpro to produce 3Cpro and 3Dpol. The activation of 3Dpol polymerase activity by cleavage of 3CDpro, a polypeptide that has no polymerase activity, can be shown by template- and primer-dependent poly(U) synthesis. Anti-VPg antibodies (VPg = 3B) added to HeLa translation extracts programmed with poliovirion RNA inhibit cleavage of 3CDpro whereas addition of purified 3AB or VPg to these translation reactions increases 3CDpro processing. 3AB stimulates also 3Cpro-related proteolysis of 2BC, a poliovirus-specific, nonstructural processing intermediate. In contrast, 3CDpro-specific cleavage of the structural precursor P1 is inhibited by the addition of 3AB as shown by a decrease in the production of VP0 and VP3. These data shed new light on a phenomenon in the regulation of expression of poliovirus genetic information: whereas the proteinase 3CDpro is needed for processing of the capsid precursor, the cleavage product of this relatively stable precursor is required for RNA replication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7929442

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Primer-dependent synthesis by poliovirus RNA-dependent RNA polymerase (3D(pol)).

Authors:  V Rodriguez-Wells; S J Plotch; J J DeStefano
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

2.  Strand-specific RNA synthesis defects in a poliovirus with a mutation in protein 3A.

Authors:  Natalya L Teterina; Mario S Rinaudo; Ellie Ehrenfeld
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Improving proteolytic cleavage at the 3A/3B site of the hepatitis A virus polyprotein impairs processing and particle formation, and the impairment can be complemented in trans by 3AB and 3ABC.

Authors:  Y Kusov; V Gauss-Müller
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Characterization of protein-protein interactions critical for poliovirus replication: analysis of 3AB and VPg binding to the RNA-dependent RNA polymerase.

Authors:  Daniel M Strauss; Deborah S Wuttke
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Nitric oxide inhibition of coxsackievirus replication in vitro.

Authors:  C Zaragoza; C J Ocampo; M Saura; A McMillan; C J Lowenstein
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  Identification of tolerated insertion sites in poliovirus non-structural proteins.

Authors:  Natalya L Teterina; Chris Lauber; Kenneth S Jensen; Eric A Levenson; Alexander E Gorbalenya; Ellie Ehrenfeld
Journal:  Virology       Date:  2010-10-23       Impact factor: 3.616

7.  Poliovirus protein 3AB displays nucleic acid chaperone and helix-destabilizing activities.

Authors:  Jeffrey J DeStefano; Oduyebo Titilope
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Genetic adaptation to untranslated region-mediated enterovirus growth deficits by mutations in the nonstructural proteins 3AB and 3CD.

Authors:  Paola Florez de Sessions; Elena Dobrikova; Matthias Gromeier
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

9.  Isolation of enzymatically active replication complexes from feline calicivirus-infected cells.

Authors:  Kim Y Green; Aaron Mory; Mark H Fogg; Andrea Weisberg; Gaël Belliot; Mariam Wagner; Tanaji Mitra; Ellie Ehrenfeld; Craig E Cameron; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Poliovirus protein 3AB forms a complex with and stimulates the activity of the viral RNA polymerase, 3Dpol.

Authors:  S J Plotch; O Palant
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.